![Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0 Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0](https://cardiology2.com/wp-content/uploads/2019/10/chrislandon_philips.jpg)
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0
![Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing](https://dev.rodpub.com/images/227/368_main.jpg)
Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing
![PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies](https://i1.rgstatic.net/publication/318590981_Stellarex_Drug-Coated_Balloon_for_Treatment_of_Femoropopliteal_Disease_12-Month_Outcomes_from_the_Randomized_ILLUMENATE_Pivotal_and_Pharmacokinetic_Studies/links/5cad58af92851ccd4ac06816/largepreview.png)
PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
![Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex 0.035 low-dose DCB - Vascular News Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex 0.035 low-dose DCB - Vascular News](https://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2020/11/Screenshot-286.png)